Research Partnership has published a new patient Living with Atopic Dermatitis (US) report

Living with Atopic Dermatitis (AD) is a report based on a new study conducted amongst adult sufferers and parents of child sufferers. The report consists of 45-minute quantitative and 30-minute qualitative interviews with 152 AD sufferers in total. An attitudinal segmentation is included to help identify the unique groups of patients Atopic Dermatitis.

The report is intended to help pharmaceutical companies that currently have or are developing products in this disease area to gain a deeper understanding of how patients come to be diagnosed with AD and how it impacts their day-to-day lives physically, emotionally and socially. It also explores patient attitudes and perceptions towards treatment and the healthcare professionals managing their condition as well as identifying the types of support patients seek at key stages of their journey.

Atopic Dermatitis affects about 20% of people at some point in their lives and around 15 million people in the United States have one or more symptoms of this disease.

Head of Living with, Mariel Metcalfe commented, “We are pleased to have conducted this study, especially since Atopic Dermatitis represent such a physical and emotional burden, not only on the patient but also their caregivers. This report provides comprehensive, quantitative insights into patient behaviours and perceptions, as well as their feelings at key stages of their journey living with AD.”